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This study aimed to determine the prevalence of metabolic syndrome (MeS) and its individual components in Jordanian children
and adolescents aged 7–18 years and determine the factors that are associated with clustering of metabolic abnormalities. MeS
was deﬁned using the International Diabetes Federation (IDF) deﬁnition. The prevalence of MeS was estimated from 512 subjects
who had complete information on all MeS components. The prevalence of MeS according to IDF criteria was 1.4% in subjects
aged between 10 and 15.9 years and 3.6% in subjects aged between 16 and 18 years. When categorized according to body mass
index (BMI), the prevalence of the MeS was 15.1% in obese subjects, compared to 0.3% in subjects with normal BMI, and 3.0%
in overweight subjects. In conclusion, our results indicate that although the prevalence of MeS is low in Jordanian children and
adolescents, a large proportion of them had one or two metabolic abnormalities.
1.Introduction
Previous studies revealed that cardiovascular diseases (CVD)
begininchildhood[1,2],andendothelialdamagemayoccur
early in the life of children with lipid abnormalities [3, 4].
The Cardiovascular Risk in Young Finns Study [5] showed
a positive correlation between the number of risk factors at
age12–18 years and carotid artery wall thickness at age 33–
39 years. Furthermore, Morrison et al. [6] showed that the
metabolic syndrome (MeS) in childhood predicts MeS and
type 2 diabetes mellitus in adulthood.
While earlier studies in childhood had focused on the
clustering of risk factors for cardiovascular diseases [7, 8],
recent studies had reported the prevalence of MeS during
childhood [9–11]. Several deﬁnitions have been proposed
for MeS in children and some of these deﬁnitions followed
the ATP III guidelines [9–14]. The International Diabetes
Federation (IDF) consensus worldwide deﬁnition of the MeS
is divided according to age-groups because of developmental
challenges presented by age-related diﬀerences in children
and adolescents: 6 –<10 years, 10 –<16 years, and ≥16 years
[15, 16].
The prevalence of the MeS varied by the deﬁnition used,
the weight status of the children, sex, and ethnicity. Cook et
al. [9] reported a prevalence of 4.2% among children and
adolescents of 12–19 years of age using the third National
Health and Nutrition Examination Survey (NHANES III)
data. A prevalence of 3.6% in youth 8–17 years of age was
reported by researchers from the Bogalusa Heart Study [17].
Much higher prevalence rates were reported in children
who were overweight or obese [9, 13], where the prevalence
reached 50% in severely obese youngsters [13].
Data pertaining to MeS in children are scarce and most
studies were conducted in developed countries with very
little is known about this syndrome in children in the
middle east and Arab countries including Jordan. Therefore,
this study aimed to determine the prevalence of MeS
and its individual components in Jordanian children and
adolescents aged 7–18 years and determine the factors that
are associated with clustering of metabolic abnormalities.2 International Journal of Pediatric Endocrinology
2. Methods
2.1. Sampling. A national population-based household sam-
ple was selected from the 12 governorates of Jordan. These
12 governorates belong to the three regions of the country,
namely, the north, middle, and south. A complex multistage
sampling technique was used to select the households,
taking into consideration the geographic distribution of the
population as well as the urban-rural residence. As the
population is covered by an extensive network of health
centers and because the study procedures have to take place
in a medical setting, the selection of households was health
center-oriented. The health director in each governorate was
contacted and asked to identify at least two health centers
in which to conduct the study procedures. He was asked to
select the health centers so that urban and rural areas in
each governorate are represented and the selected centers
have enough space to host the study team, participants, and
equipments. A total of 31 health centers were identiﬁed and
people served by these centers were targeted. A systematic
sample of households was selected from the population
served by the selected health centers. The number of
selected households was approximately proportional to the
population in each region.
In each selected area, one day before data collection, 2-
membered teams (a male and a female each) visited the
selected households, explained the purpose of the study, and
invited all members aged ≥7 years, who were available at
the time of visit, to attend the health centre in the next
day after an overnight fast. Subjects on regular medications
were asked not to take their medications early at that day
and to bring all their medications with them to the survey
site. To encourage participation, the study team worked
in all week days including oﬃcial holidays except Fridays
during the entire study period. Of the 1600 families invited
to participate, 1282 (80.1%) families (5640 subjects aged
between 7 and 90 years) took part in this study. Of the total
1290 children and adolescents (aged 18 years or less) who
were invited to participate, 1046 (81.1%) subjects responded
and participated in the study.
2.2. Data Collection. All ﬁeld work was carried out between
1st of July and 30th of November, 2009. Participants
attended the health centers in the morning (8–11am)
with a minimum fasting time of 10 hours. A pilot-tested
structured questionnaire was prepared and administered
by trained interviewers to collect relevant information that
is necessary to answer the current research question and
other selected research questions that will be addressed in
separatepublications. The questionnaire sought information
on demographics, medical history and medication use, level
ofeducation,averagemonthlyfamilyincome,andamountof
exercise per week. Information on other variables necessary
for other research questions was collected. Two questions
related to physical activity were modiﬁed from the Leisure
Time Exercise Questionnaire to assess the physical activity
of participants [18]. The two questions individually assessed
moderate and vigorous activity asking, “In the past week,
how many hours did you spend doing moderate activity”
and “In the past week, how many hours did you spend
doing vigorous activity”. More than 10 examples of common
speciﬁc activities were given after each question.
2.3. Measurements and Laboratory Analysis. Anthropometric
measurements including weight, height, waist, and hip cir-
cumferences were measured with the subjects wearing light
clothing and no shoes. Height and weight were determined
to the nearest 0.1cm. WC was measured to the nearest
centimeter using nonstretchable tailors measuring tape at
the midpoint between the bottom of the rib cage and
above the top of the iliac crest during minimal respiration.
Hip circumference was measured at the widest part of
the body below the waist. Readings of systolic (SBP) and
diastolic blood pressure (DBP) were taken in duplicates
with the subject seated and the arm at heart level, after
at least 5 minutes of rest, using standardized mercury
sphygmomanometer with appropriate arm cuﬀ length. The
mean of these two determinations was used to express the
individual’s systolic and diastolic blood pressures.
For laboratory analysis and all biochemical measure-
ments, two sets of fasting blood samples were drawn from
a cannula inserted into the antecubital vein into sodium
ﬂuoride potassium oxalate tubes for glucose and lithium
heparin vacuum tubes for lipids. Samples were centrifuged
at 3000rpm for 10min within 1 hour at the survey site,
and plasma was transferred to separate labeled tubes and
transferred immediately in cold boxes ﬁlled with ice to the
central laboratory of the National Center for diabetes and
endocrinology. All biochemical measurements were carried
out by the same team of laboratory technicians and the same
method throughout the study period.
Triglycerides values were obtained on COBAS INTEGRA
700 with the cassette COBAS INTEGRA Triglycerides using
enzymatic, colorimetric method (GPO/PAP) with glycerol
phosphate oxidase and 4-aminophenazone. Total cholesterol
was analyzed using enzymatic, colorimetric method with
COBAS INTEGRA Cholesterol Gen.2. HDL cholesterol and
LDL cholesterol values were obtained on COBAS INTEGRA
700 using homogeneous enzymatic colorimetric assay. Other
laboratory analysis was also performed for several blood
constituents, but it is not described here because they are
irrelevant to the current report.
2.4. Deﬁnition of Variables. To deﬁne MeS according to IDF
deﬁnition, age was divided into three groups: 7 to <10
years, 10 to <16, and 16 years and older. The MeS was not
diagnosed in children younger than 10 years old as stated in
theIDFdeﬁnition[15,16].Forchildrenagedbetween10and
15 years, a diagnosis of the MeS was made as the presence of
abdominal obesity (WC ≥90th percentile or adult cut-oﬀ if
lower) and the presence of two or more of the other com-
ponents: Elevated TG (≥1.7mmol/L (≥150mg/dL)), low
HDL cholesterol (<1.03mmol/L (<40mg/dL)), high blood
pressure (Systolic ≥130mmHg or diastolic ≥85mmHg),
andelevatedbloodglucose(≥5.6mmol/L(100mg/dL)).IDF
criteria for adults [19] were used to deﬁne MeS in those aged
16 years or more. Although that the MeS was not diagnosedInternational Journal of Pediatric Endocrinology 3
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Figure 1: The age distribution of Jordanian 478 boys and 568 girls
aged between 7 and 18 years.
for children younger than 10 years, other components were
deﬁned, for all subjects who had complete information
on that component, as those for children aged between
10 and 15 years. Of children and adolescents selected, 10
subjects had missing information on at least one of the
anthropometric measures, blood pressure measurements,
and lipid measurements. However, only 671 subjects had
b l o o dg l u c o s em e a s u r e m e n t s .M e Sw a sd e ﬁ n e da n dr e p o r t e d
for subjects aged 10 years or more who had complete
information on all components of MeS (n = 512).
Body mass index (BMI) was calculated as the ratio of
weight in kilograms to the square of height in meters, and
then standardized for sex and age using data from the Center
for Disease Control and Prevention (USA) [20]. Overweight
was deﬁned as a BMI between the 85th and 95th percentiles,
and obesity as a BMI greater than or equal to the 95th
percentile [21].
2.5. Data Management and Statistical Analysis. Data were
entered into computer using the Statistical Package for
Social Sciences software, SPSS (SPSS Inc., Chicago, IL,
USA) version 15. Participants’ characteristics were described
using means, standard deviations, and percentages wherever
appropriate. The diﬀerences between percentages were ana-
lyzed using χ2 test, and the diﬀerences between two means
wereanalyzedusingindependentsamplet-test.Multivariable
logistic regression models were ﬁt to determine factors
associated with various clustering of CVD risk factors
(outcome variables): at least one metabolic abnormality,
at least two metabolic abnormalities, and at least three
metabolic abnormalities. Logistic regression was conducted
using backward stepwise elimination method to reach the
“best ﬁtting model” that includes the signiﬁcant variables
only. Similar analysis was repeated for each outcome vari-
able. A P-value of less than .05 was considered statistically
signiﬁcant.
3. Results
3.1. Participants’ Characteristics. This study included a total
of 1046 subjects (478 boys and 568 girls) aged between 7 and
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Figure 2: The prevalence of metabolic syndrome among boys and
girls using the International Diabetes Federation (IDF) consensus
worldwide deﬁnition according to the age group (10–<16 year and
16–18 year).
18 years with a mean of 12.5 (3.2) year. Figure 1 shows the
age distribution for boys and girls. About 46.7% of subjects
were living in the north, 43.5% in the middle, and 9.8%
in the south of Jordan. Table 1 shows their anthropometric,
lipid proﬁle, and clinical characteristics according to age and
gender.
3.2. The Prevalence of MeS. The prevalence of MeS according
to IDF criteria was estimated from 512 subjects (235 boys,
277 girls, 345 aged 10–15.9 years and 167 aged 16–18 years)
who had complete information on all MeS components. The
prevalence of MeS according to IDF criteria was 1.4% in
subjects aged between 10 and 15.9 years (1.1% for boys and
1.9% for girls, P-value = .556) and 3.6% in subjects aged
between16and18years(3.8%forboysand3.5%forgirls,P-
value = .906) (Figure 2). There was no signiﬁcant diﬀerence
in the prevalence of MeS between the two age groups (P-
value =.117) and between boys and girls in both age groups.
When categorized according to BMI category, the preva-
lence of the MeS was 15.1% in obese subjects, compared to
0.3% in subjects with normal BMI (BMI < 85th percentile)
and 3.0% in overweight subjects.
3.3. The Prevalence of Individual Metabolic Abnormalities. In
the whole sample, the most commonly found abnormality
was low HDL cholesterol (26.1%) followed by high TG
(17.2%).Theprevalencerateswere7.2%forhighfastingglu-
cose, 6.2% for high blood pressure, and 5.8% for increased
waist circumference. About 44.4% had at least one metabolic
abnormality,16.1%hadatleasttwometabolicabnormalities,
and 4.2% had at least three metabolic abnormalities. The
prevalence of clustering of metabolic abnormalities accord-
ing to BMI is shown in Figure 3.
Table 2 shows the prevalence of individual metabolic
abnormalities for boys and girls according to age. The
prevalence for children aged ≤12 and >12 years, respectively,
was 3.2% and 8.0% for high blood pressure, 14.6% and
18.9% for high TG levels, 20.5% and 29.6% for low HDL
levels, and 3.7% and 7.1% for increased waist circumference.
The prevalence of at least one CVD risk factors was 36.5%
and 49.3%, respectively. The prevalence of obesity (waist4 International Journal of Pediatric Endocrinology
Table 1: Anthropometric, lipid proﬁle, and clinical characteristics for boys and girls according to age.
Boys Girls
≤12 >12 ≤12 >12
N Mean (SD) N Mean (SD) P-value N Mean (SD) N Mean (SD) P-value
Weight (Kg) 190 28.3 (8.3) 283 52.1 (15.5) <.005 208 29.8 (10.0) 357 52.0 (13.2) <.005
Weight Z score 190 −0.81 (0.48) 283 0.54 (0.88) <.005 208 −0.87 (0.62) 357 0.50 (0.82) <.005
Height (cm) 190 130.1 (9.3) 238 157.0 (13.0) <.005 208 131.3 (10.3) 357 154.7 (7.3) <.005
Height Z score 190 −0.91 (0.53) 283 0.61 (0.74) <.005 208 −1.04 (0.73) 357 0.61 (0.52) <.005
Body mass index (BMI) Kg/m2 190 16.5 (3.3) 283 20.8 (4.56) <.005 208 16.9 (3.5) 357 21.6 (4.5) <.005
BMI Z score 190 −0.56 (0.73) 283 0.38 (0.98) <.005 208 −0.62 (0.73) 357 0.36 (0.96) <.005
Waist circumference (cm) 193 55.7 (7.9) 283 68.9 (10.8) <.005 209 56.5 (8.3) 356 67.3 (8.7) <.005
Hip circumference (cm) 193 68.1 (7.8) 282 86.4 (11.0) <.005 210 71.4 (9.5) 356 90.9 (11.0) <.005
Systolic blood pressure 193 101.4 (9.6) 283 110.0 (12.2) <.005 210 101.1 (12.1) 355 108.5 (9.8) <.005
Diastolic blood pressure 193 66.4 (8.1) 282 70.7 (9.3) <.005 210 66.4 (9.3) 355 71.5 (8.1) <.005
Total cholesterol (mg/dL) 195 164.1 (31.7) 283 159.0 (34.1) .099 210 166.5 (32.9) 358 163.8 (31.6) .323
HDL cholesterol (mg/dL) 195 52.1 (13.9) 283 45.3 (13.0) <.005 210 49.9 (11.8) 358 48.4 (12.1) .167
LDL cholesterol (mg/dL) 195 90.1 (26.7) 283 86.6 (27.8) .170 210 92.7 (27.7) 358 89.7 (25.7) .189
Triglyceride (mg/dL) 195 96.8 (58.9) 283 113.8 (62.0) .003 210 111.8 (61.6) 358 109.4 (52.7) .618
Fasting blood glucose (mg/dL) 123 85.5 (10.4) 175 87.3 (18.8) .320 134 81.1 (10.2) 239 83.8 (15.2) .062
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Figure 3: The prevalence of clustering of metabolic abnormalities
among Jordanian children and adolescent aged between 7 and 18
years according to body mass index.
circumference),lowHDLcholesterol,highbloodpressure,at
least one metabolic abnormality, and at least three metabolic
abnormalities were signiﬁcantly higher among subjects aged
>12yearscomparedtothoseamongsubjectsaged ≤12years.
3.4. Factors Associated with Clustering of MeS Components.
MeS was signiﬁcantly associated with BMI only. None
of other variables were signiﬁcantly associated with MeS.
Childrenwithoverweightwere12.2timesmorelikelytohave
MeS (P-value = .042),andthosewithobesitywere69.5times
more likely to have MeS (P-value <. 005).
Table 3 shows the factors that are associated with the
three outcome variables: having at least one metabolic
abnormality, having at least two metabolic abnormalities,
andhavingatleastthreemetabolicabnormalities.Compared
to children aged ≤12 year, those who were older than 12
years had higher odds of having at least one metabolic
abnormality (OR = 1.6) and having at least two metabolic
abnormalities (OR = 17.2). Children living in north (OR =
2.3) and middle (OR = 2.6) were more likely to have at least
one metabolic abnormality. Compared to those with normal
BMI, children with obesity had higher odds of having at least
one, two, or three metabolic abnormalities. Children with
overweight were more likely to have at least one metabolic
abnormality only. Exercise for more than 7 hours per week
was associated with decreased odds of having at least three
metabolic abnormalities.
4. Discussion
Only few studies have assessed the prevalence of MeS
in a population-based samples of young people [9, 22–
24]. Although direct comparison across studies is diﬃcult
because of the diﬀerences in the deﬁnition of the syndrome,
the overall prevalence of MeS in Jordanian children and
adolescents (2.1%) was similar to that reported in subjects
aged from 10 to 17 years in Turkey (2.2%) [25]. Using a
deﬁnition similar to that proposed in ATP III criteria, a
prevalence of 4.2% was reported among US adolescents aged
12to19yearswhoparticipatedintheNHANESIII[9].Using
the 2007 pediatric IDF deﬁnition among US adolescents
aged 12–17 years, Ford et al. reported that the prevalence of
the MeS was approximately 4.5% [24]. In northern Mexico
children and adolescents aged 10–18 years, the prevalence
variedbetween3.8%to7.8%accordingtothedeﬁnitionused
[10]. Much higher prevalence rates were reported in Kuwaiti
female adolescents aged 10–19 years, where the prevalence
was 14.8% using IDF and 9.1% using the ATP III modiﬁed
for age diagnostic criteria [26]. Furthermore, a prevalence of
9.2%wasreportedinsubjectsaged12–19yearsinKorea[27].
Although some of the previous studies suggest that the
overall prevalence rates of the MeS in childhood are low,International Journal of Pediatric Endocrinology 5
Table 2: The prevalence of individual metabolic abnormalities for boys and girls according to age.
Age (year)
Variable
≤12 year >12 year
Boys n (%) Girls n (%) Total n (%) Boys n (%) Girls n (%) Total n (%) P-value (age groups)
Abdominal obesity .025
Yes 4 (2.1) 11 (5.3) 15 (3.7) 16 (5.7) 29 (8.2) 45 (7.1)
No 189 (97.9) 197 (94.7) 386 (96.3) 266 (94.3) 325 (91.8) 591 (92.9)
Triglycerides level .072
High 22 (11.3) 37 (17.6) 59 (14.6) 57 (20.1) 64 (17.9) 121 (18.9)
Normal 173 (88.7) 173 (82.4) 346 (85.4) 226 (79.9) 294 (82.1) 520 (81.1)
HDL cholesterol .001
Low 42 (21.5) 41 (19.5) 83 (20.5) 100 (35.3) 90 (25.1)∗ 190 (29.6)
Normal 153 (78.5) 169 (80.5) 322 (79.5) 183 (64.7) 268 (74.9) 451 (70.4)
Blood pressure .002
High 5 (2.6) 8 (3.8) 13 (3.2) 34 (12.1) 17 (4.8)∗ 51 (8.0)
Normal 188 (97.4) 202 (96.2) 390 (96.8) 248 (87.9) 337 (95.2) 585 (92.0)
Fasting blood glucose .462
Elevated 10 (8.1) 6 (4.5) 16 (6.2) 14 (8.0) 18 (7.5) 32 (7.7)
Normal 113 (91.9) 128 (95.5) 241 (93.8) 161 (92.0) 221 (92.5) 382 (92.3)
Number of metabolic
abnormalities
0 73 (59.3) 89 (67.4) 162 (63.5) 79 (45.1) 129 (54.9) 208 (50.7) .001
≥1 50 (40.7) 43 (32.6) 93 (36.5) 96 (54.9) 106 (45.1) 202 (49.3) .001
≥2 12 (9.8) 22 (16.7) 34 (13.3) 38 (21.7) 35 (14.9) 73 (17.8) .127
≥3 0 (0) 2 (1.5) 2 (0.8) 17 (9.7) 9 (3.8)∗ 26 (6.3) .001
∗Indicates a statistically signiﬁcant diﬀerence between boys and girls within age group.
Table 3: Multivariate analysis of factors associated with having at least one metabolic abnormality, having at least two metabolic
abnormalities, and having at least three metabolic abnormalities.
≥1 component ≥2 components ≥3 components
Age (year) OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
≤12 1 1
>12 1.6 (1.1, 2.4) .010 17.2 (2.2, 30.7) .006
Body mass index
Normal 1
Overweight 2.2 (1.3, 3.7) .005 1.8 (0.9, 3.5) .083 1.3 (0.3, 4.7) .727
Obesity 7.4 (3.6, 15.4) <.005 6.2 (3.4, 11.4) <.005 6.7 (2.6, 17.5) <.005
Region
North 2.3 (1.4, 3.7) <.005
Middle 2.6 (1.4, 4.6) .002
South 1
Regular activities
≤7h o u r s / w e e k 1
>7h o u r s / w e e k 0.3 (0.1, 0.8) .013
the perspective is very diﬀerent in overweight and obese
adolescents. In this study, the prevalence of the MeS was
0.3% in subjects with normal BMI, 3.0% in overweight
subjects, and 15.1% in obese subjects. This ﬁnding is similar
to that reported by others who reported that the prevalence
is much higher among obese children and adolescents.
In some studies, the prevalence approximated 30%–50%
among obese children and adolescents [9, 13, 25, 27–29].
In the whole sample, the most commonly found abnor-
mality was low HDL (26.1%) followed by increased TG
(17.2%). In contrast, the prevalence rates were 7.2% for high
fasting glucose, 6.2% for high blood pressure, and 5.8% for6 International Journal of Pediatric Endocrinology
increased waist circumference. In US adolescents, the most
common abnormality was high triglycerides and low HDL
cholesterol [9]. In the same study, the prevalence rate of high
fasting glucose was very low (1.5%).
In our study, BMI deﬁned obesity was signiﬁcantly
associated with increased odds of clustering of metabolic
abnormalitiesinthemultivariateanalysis.Theroleofobesity
and insulin resistance in the etiology of the metabolic
syndrome has been explored in children in other studies
[14, 30]. Our ﬁnding is in agreement with that reported by
others [31, 32]. Chu et al. [31] reported that the prevalence
of two or more cardiovascular risk factors was four to ﬁve
times greater in obese than in nonobese children.
Having regular physical activity of more than 7 hours per
week was associated with lower odds of MeS. Low levels of
physicalactivitywereidentiﬁedinotherstudiesasapotential
modiﬁable factor associated with metabolic risk in children,
and habitual physical activity and aerobic ﬁtness were shown
to be inversely associated with the MeS score [33–35]. This
association was shown in some studies to be independent of
adiposity [36, 37].
This study showed that subjects living in the north or
m i d d l er e g i o n sw e r em o r el i k e l yt oh a v eM e Sc o m p a r e dt o
those living in the south. This ﬁnding might be explained
by the diﬀerences in the socioeconomic and nutrition
status between the three regions of Jordan. Previous reports
supported the association between socioeconomic status and
the MeS among children, and the potential mechanisms sug-
gested were low birthweight, poor nutrition, and inadequate
physical activity [38, 39].
The associations between studied variables and MeS
should be interpreted with cautious since we cannot infer
causality from our ﬁndings because this study is cross-
sectional and some studied variables such as physical activity
were self-reported.
In conclusion, our results indicate that although the
prevalence of MeS is low in Jordanian children and adoles-
cents, a large proportion of them had one or two metabolic
abnormalities.
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